ERBB2 and breast cancer: AC treatment for 24 h resulted in a significant (P < 0.05) cytotoxic effect on both HER-2/neu-overexpressing MDA-MB-453 and BT-474 breast cancer cells with an IC50 of 220 and 240 μg/mL, respectively (Figures 1(a) and 1(b)).